Driver FixRecommendedSound, Wi-Fi or graphics acting up? Check drivers firstFind missing or outdated drivers fast.Check DriversOctober DealsAmazon USOctober deal check: compare before you payAmazon US: current deals, useful picks and tech finds.Check DealsClean PCRecommendedOne scan can reveal what keeps slowing WindowsLook for cleanup and repair opportunities.Run Scan×
Skip to content
The Finance Base
The Money Desk · Blog
Re:

How Regeneron Uses IT to Support Drug Discovery

Regeneron’s technology transformation centered on connected data and scalable research computing, supporting scientists rather than replacing laboratory validation.
From TheFinanceBase Team5 min to read

Free tools Windows power users keep installed

One-click scans. No signup required.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Regeneron’s “turn to IT” was a data and research-computing transformation—not an attempt to have AI invent medicines on its own. The company moved scientific data toward cloud infrastructure and built platforms to help researchers find, connect, and analyze it. That can speed the cycle between a scientific question and an experiment, but laboratory validation and clinical testing remain essential.

What Regeneron changed—and when

A CIO.com report published November 4, 2022 described a transformation led by then-CIO Bob McCowan. Regeneron began migrating workloads to Amazon Web Services (AWS) in late 2018. The report said about 60% of company data had moved to the cloud by 2020, and described AWS as the core of a multicloud environment that also used Microsoft Azure and Google Cloud Platform for selected capabilities.

The same account reported AWS data lakehouses holding roughly 200 terabytes of data. These are figures reported in 2022, not current measurements. They illustrate the scale and direction of the program, but do not by themselves show that cloud migration shortened drug-development timelines or lowered research costs.

The problem was access and context, not just storage

Large pharmaceutical organizations generate data across genetics, laboratory experiments, clinical safety, manufacturing, and other functions. Storing those records is only a first step. If data sits in separate systems, uses inconsistent formats, or lacks useful metadata, scientists may struggle to find it, interpret it, combine it with other evidence, or reuse it in a new analysis.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.
#1 Best Overall
TLC Plate Cutter for Glass TLC Plates
  • Saves money by eliminating the purchase of high-priced pre-cut plates
  • Operates easily and cuts plates precisely
  • Eliminates waste - use exactly the size plate you need for your work
  • Scores any coated glass plate and cuts to any size

That creates a practical obstacle for analytics and machine learning: a model cannot make disconnected, poorly described, or unreliable data useful simply by being sophisticated. The CIO.com account emphasized making data more reliable, discoverable, and prepared for analysis. The underlying work therefore includes data engineering, metadata, governance, and links between scientific systems—not only compute capacity.

How the platforms fit together

The 2022 account described two Regeneron capabilities aimed at different parts of research data work. The platforms were presented as internal research tools, not as generally available commercial products.

Capability Role described in the 2022 report
Deva Platform A research-computing platform intended to simplify and scale early-discovery analysis, abstracting some of the underlying computing environment so researchers could focus more on analytical work.
MetaBio Data Discovery Platform A cloud-based data platform offering data services, data-management capabilities, and machine-learning tools to help researchers find, understand, connect, and analyze complex biological data.

In practical terms, a platform stack of this kind can help move work from data ingestion and organization to discovery, computation, and analysis. It does not make the scientific interpretation automatic: researchers still need to judge whether a pattern is meaningful and what experiment could test it.

Rank #2
DSC MTC Bio C1500 500mL Centrifuge Tubes, Sterile Polypropylene Screw-Cap, High RCF, Ideal for Cell Harvesting & Drug Discovery, RNase/DNase/Pyrogen-Free, 40 Tubes per Case (Pack of 5 Tubes)
  • 500mL screw-cap polypropylene tubes are manufactured of polypropylene for temperature and chemical resistance. These tubes are intended for large volume centrifugation and are widely used in cell harvesting/purification and drug discovery applications. MTC Bio's 500mL centrifuge tubes can withstand up to 6,000xg maximum RCF*. They are supplied in sterile, RNase, DNase, and pyrogen-free packs of 5 tubes, 40 tubes per case.
  • Ideal for Large Volume Centrifugation: Perfect for cell harvesting/purification and drug discovery applications
  • High Maximum RCF: Can withstand up to 6,000xg for efficient and reliable sample separation
  • Sterile & Contaminant-Free: Supplied in packs of 5 tubes, RNase, DNase, and pyrogen-free for uncompromised results
  • 40 Tubes per Case: Stock up on quality centrifuge tubes for your laboratory needs

Why human genetics matters to the data strategy

The Regeneron Genetics Center (RGC) studies human genetic variation alongside clinical and molecular information to identify biological relationships that may be relevant to disease. Regeneron describes its use of de-identified clinical, genomic, proteomic, and other molecular data from properly consented volunteers in its 2025 Form 10-K. The filing reports that RGC had sequenced more than 3 million samples.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

The scientific logic is a chain of evidence, not a shortcut from a gene to a medicine. A genetic association can suggest a biological target; that target then needs validation and assessment for whether it can be safely and effectively influenced. Regeneron’s account of its scientific journey describes cloud-based analysis of genes, proteins, health records, and other data alongside laboratory automation and experimental work.

  1. Researchers identify a possible disease-related genetic or molecular signal.
  2. They assess whether the signal points to a plausible biological target.
  3. Experiments test the hypothesis and add new evidence to the data environment.
  4. Promising candidates proceed through preclinical work and, if warranted, clinical development and regulatory review.

A genetic association is evidence to investigate, not proof that changing the target will produce a safe or effective treatment.

IT complements Regeneron’s biological platforms

Cloud services and research-computing tools are one part of the system. Regeneron’s proprietary VelociSuite supplies specialized biological technologies used in areas such as antibody discovery, target validation, disease models, and therapeutic development. Regeneron lists platforms including VelociGene, VelocImmune, VelociMab, Veloci-Bi, VelociHum, VelociT, VelociVax, and Velocinator.

The distinction matters: IT infrastructure helps organize, connect, and compute over information; biological platforms help create and test experimental systems and therapeutic candidates. Their value lies in how they support one another. Data analysis can guide which experiments to run, and laboratory results can refine the next analysis. Regeneron’s R&D overview describes its broader use of data-driven research and proprietary technologies.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Why this is not an “AI discovers drugs” story

Computational tools can help researchers find patterns, prioritize targets, predict properties, and design experiments. They cannot establish clinical benefit or safety by themselves. A predicted interaction is not therapeutic activity; activity in a dish is not proof of benefit in an animal or person; and promising early evidence is not regulatory approval.

Rank #4
Prime Screen® Multi-Drug Urine Test Cup - 12 Panel Drug Test - Instant Testing Marijuana (THC),OPI,AMP, BAR, BUP, BZO,COC, mAMP, MDMA, MTD, OXY, PCP - [5 Pack]
  • RELIABLE: CLIA Waived for home or over-the-counter (OTC) use. Same technology used as Lab screening test. Results are accepted in most professional and clinical settings.
  • COMPREHENSIVE: This lab grade test can detect 12 drugs simultaneously: THC,OPI,AMP, BAR, BUP, COC, mAMP, MDMA, MTD, OXY, PCP, TCA
  • ACCURATE: More than 99% accurate; Lab recommended cutoff level: AMP - 1000 ng/mL; BAR - 300 ng/mL; BUP - 10 ng/mL; BZO - 300 ng/mL,COC - 300 ng/mL; mAMP/MET - 1000 ng/mL; MDMA - 500 ng/mL; MOP/OPI - 300 ng/mL; MTD - 300 ng/mL; OXY- 100 ng/mL; PCP- 25 ng/mL; THC - 50 ng/mL
  • EASY TO USE: Simply remove cap, collect urine in test cup, wait a FULL 5 minutes and read result; The disposable plastic gloves are INCLUDED. It is negative if 2 lines appear, and it is positive if only control line apperars. NOTE: A faint test line still means negative, and DO NOT read result AFTER 5 minutes.

The workflow is iterative: collect and organize data, identify a hypothesis, design an experiment, analyze the result, and update the next question. Wet-lab research and scientific judgment remain central. IT can make that loop more accessible and computationally scalable, but it does not replace the loop.

Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Support on Ko-Fi

The trade-offs behind cloud and multicloud

Scalability comes with variable costs

Cloud capacity can be provisioned as needed rather than limited to a fixed on-premises environment. But usage-based billing means storage, requests, retrieval, data transfer, replication, and compute can all affect cost. AWS describes its pricing approach, including pay-as-you-go options; its S3 pricing and EC2 pricing pages detail usage-related charges. Repeated processing, duplicated data, idle resources, and data movement can make costs difficult to predict. Cloud adoption does not guarantee a lower total cost.

Multiple providers add flexibility and complexity

Using more than one cloud can give teams access to different services, but it also creates work in identity and access management, monitoring, compliance, data movement, and reproducible environments. A multicloud design is useful when there is a clear scientific or business reason for it; it is not inherently better than a well-governed single-cloud architecture.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.
Best Value
DSC MTC Bio C1250 Premium 250mL Polypropylene Centrifuge Tubes - Sterile, Leak-Proof, Graduated, Ideal for Cell Harvesting & Drug Discovery (Pack of 5, 70 Tubes/Case)
  • High-quality polypropylene material: Offers excellent temperature and chemical resistance for reliable performance in various applications
  • Large volume capacity: 250mL size ideal for cell harvesting, purification, and drug discovery
  • Accurate measurements: Molded graduations from 0.5 to 250mL for precise liquid handling
  • Safe and sterile: Tubes are free from RNase, DNase, and pyrogens, ensuring the utmost purity for your samples
  • Leak-proof design: Secure screw-cap seal prevents leakage and maintains sample integrity, withstanding up to 6,000xg maximum RCF*

Governance and privacy must be built in

Genomic and clinical information is sensitive even when identifiers are removed, because de-identification does not eliminate every possibility of re-identification. Regeneron’s filing describes consent and blinded analysis practices; the broader lesson for any organization is to govern consent scope, permitted use, access, audit trails, provenance, and applicable geographic or regulatory restrictions from the start.

Platforms require people and process

Cloud infrastructure alone does not harmonize scientific data or connect computation to experiments. A functioning research platform also depends on domain-specific data models, bioinformatics and cloud-engineering expertise, integration with laboratory systems, reproducible pipelines, validation procedures, security, and sustained collaboration between IT and scientists.

What the public evidence does—and does not—show

The reported cloud migration, data-lake scale, and platforms show that Regeneron invested in infrastructure intended to support research. The company’s current scientific materials and 2025 filing also describe a large genetics effort and the integration of computation, automation, and laboratory science. These facts do not establish a quantified reduction in discovery time, an increase in clinical success rates, a specific R&D cost saving, or a causal link between cloud migration and any particular approved medicine.

For biotech technology leaders, the useful lesson is to measure whether scientists can find and reuse trustworthy data, launch analyses more easily, reproduce results, and move from hypothesis to well-designed experiment. Cloud adoption is an input; the scientific and operational outcomes are what matter.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.

Leave a Reply

Your email address will not be published. Required fields are marked *

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

More post from the Money Desk

  1. The Money DeskBlogTheFinanceBase09 OCT 267 minMortgage Escrow FAQs: Taxes, Insurance, Shortages, and Refunds
  2. The Money DeskBlogTheFinanceBase09 OCT 265 minHow Mortgage Escrow Accounts Work and What Homeowners Pay For
  3. The Money DeskBlogTheFinanceBase09 OCT 265 minHow to Read a Stock Chart, Volume and Market-Cap Data
Recommended PC Tool
Recommended PC Tool
Windows Errors? Fix Them Before They SpreadFree repair scan
Outdated Drivers Are Slowing You DownFree scan - exact matches

Two free Windows tools

One Free Minute Could Fix That PC

Before you go - each of these free tools takes about a minute and tackles what quietly slows a Windows PC down.

Special offer. View Outbyte info, uninstall instructions, EULA, and Privacy Policy.